lobbying_activities: 599271

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
599271	2c29674f-21f5-4a5f-bc5a-9a52ce3eef4d	Q1	TARPLIN, DOWNS & YOUNG, LLC	304736	WYETH	2008	first_quarter	PHA	see addendum page FDAAA Implementation Biosimilars H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/H.R.1038 - Access to Life- Saving Medicine Act, Follow-On Biologics S. 1695 - Biologics Price Competition and Innovation Act of 2007 S. 1505 - Affordable Biologics for Consumers Act H.R. 5629, the "Pathway for Biosimilars Act." Import Safety H.R. 3610 - Food and Drug Import Safety Act of 2007 **, no specific bill(s), Biosimilars, Drug Safety, Prescription Drug Importation, Import Safety	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	40000		0	0	2008-04-18T12:56:15-04:00